Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Bacterial Infections

Explore clinical trials studying Central Nervous System Bacterial Infections. Study availability and eligibility vary by location and protocol.

178 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Bacterial Infections trial results

Completed

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

NCT03621670

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
View all 57 locations
View Trial Details
Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

NCT03547271

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Investigational Site Number : 2031006 Chlumec nad Cidlinou, Czechia
  • Investigational Site Number : 2031013 Domažlice, Czechia
  • Investigational Site Number : 2031010 Jindřichův Hradec, Czechia
  • Investigational Site Number : 2031012 Jindřichův Hradec, Czechia
View all 33 locations
View Trial Details

Related conditions